Product Description
Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml.
Biovision | 4706 | Apolipoprotein CIII Human Plasma DataSheet
Biomolecule/Target: N/A
Synonyms: Apolipoprotein CIII
Alternates names: Apolipoprotein CIII, apolipoprotein, apolipoproteins
Taglines: Transportor of lipids through the lymphatic and circulatory systems
NCBI Gene ID #: 345
NCBI Gene Symbol: APOC3
Gene Source: N/A
Accession #: P02656
Recombinant: No
Source: Human Plasma
Purity by SDS-PAGEs: 95%
Assay: SDS-PAGE
Purity: N/A
Assay #2: HPLC
Endotoxin Level: N/A
Activity (Specifications/test method): N/A
Biological activity: N/A
Results: N/A
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: 8.750 kDa
Concentration: N/A
Appearance: Liquid
Physical form description: Frozen in 10 mM NH4HCO3 , pH 7.4
Reconstitution Instructions: N/A
Amino acid sequence: N/A